CD20 antibodies induce production and release of reactive oxygen species by neutrophils-Reference-Cited by-同舟云学术

CD20 antibodies induce production and release of reactive oxygen species by neutrophils

Published:2014-06-19 Issue:25 Volume:123 Page:4001-4002
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Werlenius Olle¹,Riise Rebecca E.²,Simpanen Maria¹,Aurelius Johan²,Thorén Fredrik B.²^ORCID

Affiliation:

1. Sahlgrenska Cancer Center and Department of Hematology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

2. Sahlgrenska Cancer Center and Department of Infectious Diseases, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/123/25/4001/1464614/4001.pdf

Reference6 articles.

1. Glycoengineered CD20 antibody obinutuzumab activates neutrophils and mediates phagocytosis through CD16B more efficiently than rituximab.;Golay;Blood,2013

2. Measurement of respiratory burst products, released or retained, during activation of professional phagocytes.;Bylund;Methods Mol Biol,2014

3. Rituximab-dependent cytotoxicity by natural killer cells: influence of FCGR3A polymorphism on the concentration-effect relationship.;Dall’Ozzo;Cancer Res,2004

4. Rituximab-mediated antibody-dependent cellular cytotoxicity against neoplastic B cells is stimulated strongly by interleukin-2.;Golay;Haematologica,2003

5. Histaminergic regulation of NK cells. Role of monocyte-derived reactive oxygen metabolites.;Hellstrand;J Immunol,1994

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The arming of NK cells with Fc-engineered rituximab confers them specificity against CD20-expressing cells;2024-03-11

2. Role of Phosphoinositide 3-Kinase in Regulation of NOX-Derived Reactive Oxygen Species in Cancer;Antioxidants;2022-12-28

3. Natural Killer Cells in Chronic Lymphocytic Leukemia: Functional Impairment and Therapeutic Potential;Cancers;2022-11-24

4. Molecular Aspects of Resistance to Immunotherapies—Advances in Understanding and Management of Diffuse Large B-Cell Lymphoma;International Journal of Molecular Sciences;2022-01-28

5. Idelalisib Rescues Natural Killer Cells from Monocyte-Induced Immunosuppression by Inhibiting NOX2-Derived Reactive Oxygen Species;Cancer Immunology Research;2020-09-23